Pharmacist Prescriptive Authority
This course consists of 3 content modules on hormonal contraception, smoking cessation and opioid antagonists. Each module may be taken individually, or together as a full course. This course will meet the expected training requirements from the Minnesota Board of Pharmacy for pharmacists to be able to prescribe hormonal contraception, nicotine replacement therapy, and opioid antagonists. Each module is designed to build on the pharmacist's existing clinical knowledge and prepare the pharmacist for the initial assessment, selection of appropriate therapies, and adjusting therapies based on patient outcomes. Course modules will have a significant focus on application of clinical knowledge to patient cases.
Pharmacist Prescriptive Authority consists of three (3) modules which can be completed separately. Each module has one or more presentations and a short assessment. Participants will be required to pass (70% or better) on the assessment, complete the module evaluation and submit a verification.
- Describe mechanisms of action of hormonal contraceptive agents.
- Describe initiation, contraindications, precautions, and adverse effects of all hormonal contraceptives, including drug-drug interactions.
- Assess a patient and determine most appropriate hormonal contraception, in alignment with evidence, clinical guidelines (CDC MEC), and individual patient characteristics and preferences.
- Develop an appropriate care plan, including education and follow-up for a patient using hormonal contraception.
- In a patient experiencing side effects from combined hormonal contraceptives (CHCs) , determine hormone imbalance causing the side effect & recommend appropriate changes.
Smoking Cessation: Nicotine Replacement
- Summarize mechanisms of action for nicotine replacement products and other smoking cessation therapies.
- Describe how to apply the Minnesota Pharmacist Prescribing Protocol.
- Assess patients' readiness to quit.
- Develop a patient specific care plan for smoking cessation.
- Describe adverse effects and risk of harm with smoking cessation therapies.
- Describe the mechanism of action for opioid antagonists.
- List risk factors for opioid overdose.
- Compare and contrast available options for naloxone products.
- Describe various methods to start a conversation with patient about opioid antagonists.
- Explain how the Minnesota Pharmacist Prescribing Protocol can be used in harm reduction strategies to reduce opioid overdose deaths.
Heather Blue, PharmD, BCPS
Dr. Heather Blue is an Assistant Professor at the University of Minnesota College of Pharmacy- Duluth campus. She completed her PharmD at the University of Minnesota and after a PGY1 residency, worked as clinical pharmacist at Mercy Hospital-part of the Allina Health System. Her current research is based on her clinical practice in the emergency department at St. Luke’s Hospital Duluth, with an emphasis in opioid overdose reduction strategies. Dr. Blue has initiated a naloxone take-home program from the emergency department and is collaborating with community partners to create supports for people with substance use disorder including emergency department initiated buprenorphine.
Jean Moon, PharmD, BCACP
Dr. Moon is an associate professor for the University of Minnesota (U of MN) College of Pharmacy and adjunct associate professor at the U of MN School of Medicine. She is clinical faculty for the U of MN North Memorial Family Medicine Residency Program where she provides comprehensive medication management services for a medically underserved patient population in North Minneapolis in addition to teaching pharmacy and medical students and residents. Dr. Moon is the Program Director for the U of MN College of Pharmacy PGY-1 Pharmacy Residency Program. She received her Doctor of Pharmacy and completed a PGY1 pharmacy residency in 2005 from the U of MN College of Pharmacy. Dr. Moon has a clinical interest in pulmonary medicine and smoking cessation.
Laura Palombi, PharmD, MPH, MAT, AE-C
Laura Palombi is an associate professor at the University of Minnesota – College of Pharmacy in Duluth and has an appointment as an affiliate assistant professor at the University of Minnesota School of Public Health. Dr. Palombi graduated with her PharmD from the University of Minnesota College of Pharmacy in 2012 and completed a PGY1 residency with the University of Minnesota’s ambulatory care pharmacy program in 2013.
Dr. Palombi’s academic focus is on community engagement and public health. She is an active member of the Carlton County Drug Court team, the Carlton County Drug Prevention Coalition, the Pine County Chemical Health Coalition, the Substance Abuse Coalition of Kanabec County, and St. Louis County’s Opioid Abuse Response coalitions. She was recognized in 2017 with the President’s Civic Engagement Steward Award and the Cardinal Health Generation Rx Award, both in recognition for her work partnering with Minnesota communities to address substance use.
Chrystian Pereira, PharmD, BCPS
Chrystian Pereira, Pharm.D., BCPS, BCACP is an Associate Professor at the University of Minnesota College of Pharmacy in the department of Pharmaceutical Care and Health Systems. He is a faculty member at Smiley’s Family Medicine Residency where he both practices as a clinical pharmacist and trains various learners. Dr. Pereira is a member of the University of Minnesota’s 1Health interprofessional education curriculum development team and is committed to instilling the values of collaborative medicine into the teaching curriculum. Dr. Pereira’s areas of interest are in quality improvement, improving community health, and the study of the medication experience.
Sarah Westberg, PharmD, FCCP, BCPS
Dr. Westberg is currently a Co-Associate Dean for Clinical Affairs and a Professor in the College of Pharmacy at the University of Minnesota. She graduated with her Pharm.D. from Drake University, completed a Pharmaceutical Care Leadership Residency at the University of Minnesota, and then joined the University of Minnesota faculty. She has been providing comprehensive medication management services at the Women’s Health Specialists Clinic at MHealth Fairview for 12 years and teaches women’s health topics within the Pharm.D. program.
Credit Designation Statement
In support of improving patient care, this activity is planned and implemented by The National Center for Interprofessional Practice and Education and the University of Minnesota College of Pharmacy. The National Center for Interprofessional Practice and Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Hormonal Contraception: This activity is designated for 4.25 CPE contact hours (CEUs) through ACPE. UAN is JA4008105-0000-21-032-H04-P.
Smoking Cessation: Nicotine Replacement: This activity is designated for 2.0 CPE contact hours (CEUs) through ACPE. UAN is JA4008105-0000-21-033-H04-P.
Opioid Antagonists: This activity is designated for 1.5 CPE contact hours (CEUs) through ACPE. UAN is JA4008105-0000-21-034-H04-P.
Registration and Fees
Registration for Pharmacist Prescriptive Authority is currently available. Register now.
There is no fee for this course.
For questions about the course, please contact the Continuing Pharmacy Education office at firstname.lastname@example.org.